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Objective: Motivation is theorized to be a key determinant of behavior but has not been applied 
to human papillomavirus (HPV) vaccination. Autonomous motivation is hypothesized to be the 
most "self-determined" type of motivation and may contribute to parents' decisions to initiate and 
complete the HPV vaccine series. I examined patterns of association between motivation types 
and HPV vaccination as well as the pathways linking autonomous motivation with intentions to 
vaccinate. 
Methods: As part of a larger project, parents (N=177) of unvaccinated adolescents completed a 
survey including a measure of parental motivation for adolescent vaccination. After 12 months, I 
reviewed electronic medical records to obtain HPV vaccination coverage data. I used logistic 
regression models to determine which motivation types—autonomous, introjected, or external—
were associated with one- and three-dose coverage. I examined ordinal regression models to 
assess the overall effect of motivation on HPV vaccine coverage. Additionally, I tested 
competing models of the direct effect of autonomous motivation and the indirect effect through 
other psychosocial variables to determine which pathway(s) best explain the relationship 
between autonomous motivation and intentions to vaccinate.  
Results: Results indicate autonomous motivation is a significant predictor of 1-dose coverage 
(OR = 2.47; 95%CI: [1.202, 5.079], p = .01) and of 3-dose coverage (OR = 2.68; 95%CI: [1. 00, 
7.18], p = .05). Ordinal regression models confirmed greater autonomous motivation is 
associated with increased likelihood of pursuing HPV vaccine coverage (OR = 2.452, 95% CI = 
1.257 - 4.786, p = .009). There were no significant effects of introjected or external motivation 
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on one- or three-dose coverage (ps > .142). Moreover, a model with both direct effects of 
autonomous motivation on intentions and indirect effects via attitudes best fit the data. 
Conclusions: Findings support the utility of distinguishing the type of underlying motivation for 
adolescent HPV vaccination. Autonomous motivation, rather than introjected and external 
motivation, was positively associated with one- and three-dose coverage. Thus, autonomy-
supportive interventions to promote parents’ beliefs that the HPV vaccine is important and 
beneficial to their child's health may be a useful mechanism for increasing rates of completion of 
the vaccine series.   
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The Influence of Parental Autonomous Motivation on Adolescent HPV Vaccine Initiation and 
Completion 
Despite well-demonstrated benefits of vaccinating against human papillomavirus (HPV), 
including protection against several types of cancer and genital warts, rates of adolescent vaccine 
coverage remain low. Motivation is theorized to be a key determinant of behavior (Deci & Ryan; 
1985), and research has demonstrated autonomous motivation—motivation due to the experience 
of volition and belief in the value and importance of a behavior—facilitates behavior 
performance and maintenance (Ryan & Deci, 2000). Accordingly, autonomous motivation may 
be influential in decisions to receive the required three doses of the HPV vaccine. Autonomous 
motivation, more than other types of controlled motivation, may contribute to parents’ decisions 
to get the first dose of the vaccine as well as decisions to return for follow-up doses. The current 
study tested the effects of motivation on HPV vaccine initiation and completion and explored the 
pathways by which motivation might influence parents' decisions to vaccinate their children. 
Since the inception of the HPV vaccine in 2006, vaccine initiation and completion rates 
have been suboptimal. Although HPV is the leading cause of cervical cancer, anogenital cancer, 
and genital warts (CDC, 2015), series initiation (65.1% for girls and 56% for boys) and 
completion (49.5% for girls and 37.5% for boys) rates remain below the Healthy People 2020 
goal of 80% three-dose coverage (Office of Disease Prevention and Health Promotion [ODPHP], 
2016; Walker et al., 2017). The CDC (Walker et al., 2017) recommends the vaccine for girls and 
boys ages 11 to 12 and catch-up vaccination for men up to age 21 and women up to age 26. 
Previous guidelines were for all individuals to receive three doses of the vaccine. However, in 
the fall of 2016, the Advisory Committee on Immunization Practice (ACIP) changed their 
recommendation for individuals initiating the vaccine series before their 15th birthday to two 
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doses received six months apart (Robinson et al., 2018). For individuals beginning the series on, 
or after, their 15th birthday, the recommendation is to receive three doses of the vaccine (on a 0, 
2-, and 6-month schedule; Robinson et al., 2018). Despite receipt of doctor’s recommendation, 
many parents remain undecided about the HPV vaccine and fail to vaccinate their children. 
Completion of the vaccine series is key to cancer prevention as partially vaccinated individuals 
may not be entirely protected from HPV (Widdice et al., 2011), and factors impeding completion 
must be clarified. Reviews of the literature have identified factors influencing vaccine initiation 
(Bartlett & Peterson, 2011; Garcini et al., 2012; Kessels et al., 2012); however, predictors of 
completion have been largely ignored (Holman et al., 2014). Self-Determination Theory (SDT) 
suggests that behavior will be initiated and maintained if it is autonomously motivated (Deci & 
Ryan, 1985, 2008). Concerning HPV vaccination, successful initiation and completion of the 
vaccine series is theorized to result from personally valuing vaccination and its associated health 
benefits (i.e., cancer and genital wart prevention). Thus, autonomous motivation may be an 
influential factor in decisions to vaccinate.  
Self-Determination Theory posits that motivation occurs along a continuum, from self-
determined to controlled (Deci & Ryan; 1985; Deci & Ryan, 2008; Williams et al., 1996). 
Autonomous motivation is considered to be the most “self-determined” form of motivation and 
underlies behaviors performed because they are valued and believed to be important. Further, 
autonomous motivation entails internalization of values. For example, an autonomously 
motivated parent might get the HPV vaccine for their adolescent because it matches with an 
overall goal of supporting their child’s health. External motivation underlies behaviors 
performed due to outside pressures and is the most “controlled” type of motivation. External 
motivation implies no internalization of beliefs and underlies behavior performed to gain a 
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reward or avoid a punishment (Ryan et al., 2008; Williams et al., 1996; Williams et al., 2006). A 
parent who vaccinated their adolescent to make their partner or their healthcare provider happy 
would do so because of external motivation. In the middle of the spectrum, between autonomous 
and external motivation, is introjected motivation. Introjected motivation is theorized to describe 
partially internalized beliefs and values (Howard, Gagné, & Bureau, 2017; Ryan et al., 2008; 
Williams et al., 1996; Williams et al., 2006). Behaviors inspired by introjected motivation are 
performed to avoid a sense of guilt or shame. For example, a parent vaccinating their adolescent 
to avoid feeling bad about himself/herself would do so because of introjected motivation. In the 
context of HPV vaccination, one would expect parents who are autonomously motivated to 
vaccinate their adolescents to be most likely to initiate the series. 
Individuals who are autonomously motivated are more likely to perform health behaviors 
(Deci & Ryan, 2008). The positive effect of autonomous motivation on health behavior 
performance has been demonstrated across a wide variety of behaviors including physical 
activity performance, weight loss, smoking cessation, and diabetes management (Kennedy, 
Goggin, & Nollen, 2004; Williams et al., 1996; Williams et al., 2002). Theoretically, increased 
identification with values will lead to an increased sense of personal volition (Deci & Ryan, 
2008). In contrast, studies examining introjected and external motivation demonstrate neutral or 
negative associations with health behaviors such as physical activity performance, weight loss, 
and glycemic control (Edmunds, Ntoumanis, & Duda, 2006; Levesque et al., 2007; Standange, 
Sebire, & Loney, 2008; Williams et al., 1996; Williams et al., 2002; Wilson, Rodgers, & Fraser, 
2002; Wilson et al., 2003; Wilson et al., 2006). Taken together, findings from work in other 
health domains suggest that differentiating between types of motivation may be beneficial for 
promoting HPV vaccination. 
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Previous work examining HPV vaccination has identified several factors that are 
associated with HPV vaccine initiation (Brewer et al., 2011; Fuchs et al., 2016; Gerend & 
Shepherd, 2012; Thomas et al., 2012). Intentions, or plans to attain a behavioral goal, 
significantly predict initiation of the HPV vaccine (Brewer et al., 2011; Gerend & Shepherd, 
2012). Attitudes, or beliefs about the outcome of health-related behavior, are also related to 
vaccine initiation, and this effect is proposed to occur through attitudes impact on intentions 
(Ajzen, 1996; Bastani et al., 2011; Gerend & Shepherd, 2012). However, intentions do not 
necessarily translate into behavior, and these variables leave a considerable amount of variance 
in behavior unexplained (Hagger et al., 2002; Norman & Conner, 2005; Sheeran & Abraham, 
2003).   
Examining motivation can give insights into the reasons parents engage in behavior, so 
motivation, theorized to be an antecedent to intentions (Hagger & Chatzisarantis, 2014), may 
explain variance in decisions to vaccinate above and beyond parents' intentions. A parent may be 
compelled to vaccinate their adolescent because they believe vaccination will be best for their 
child's future health, to avoid feelings of guilt, or because they are seeking the approval of their 
doctor.  SDT, however, suggests that more self-determined forms of motivation are more likely 
to lead to behavioral adoption than controlled types of motivation (Deci & Ryan, 2000). While 
parents may be motivated to vaccinate their children for a variety of reasons, parents who 
experience autonomous motivated may be more inclined to move forward with vaccination than 
parents with greater introjected or external motivation (Deci & Ryan, 2000; Howard, Gagné, & 
Bureau, 2017).  While studies have examined the influence of motivation as it pertains to other 
health behaviors (e.g., smoking cessation, weight loss), it has not been applied to studies of 
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vaccination behavior. Accordingly, autonomous motivation may hold promise in facilitating 
decisions to initiate the vaccine series. 
Despite an accumulation of studies examining predictors of vaccine initiation, a review of 
the literature by Holman and colleagues (2014) found there is relatively little work exploring 
predictors of vaccine completion. Researchers have, however, identified several barriers 
impacting completion including forgetting, lacking awareness of the necessity of follow-up 
doses, and being too busy to return to the clinic (Holman et al., 2014; Kouyoumdjian & 
Bailowitz, 2011). Information on psychological factors that facilitate completion will allow us to 
address suboptimal completion rates.  
One factor that may contribute to low completion rates is differences in types of 
motivation. For example, autonomous motivation may explain which parents return to obtain 
follow up doses of the HPV vaccine to complete the series. Deci and Ryan (1985) suggested that 
the distinction between self-determined and controlled motivation is of particular importance in 
the prediction of the long-term maintenance of behavior. Several studies support the relationship 
between autonomous motivation and maintenance of various health behaviors, such as weight 
loss (Williams et al., 1996), smoking cessation (Williams & Deci, 1996; Williams et al., 2006), 
and medication adherence (Williams et al., 2009). The effect of autonomous motivation on 
behavior maintenance is also evident in HIV-medication adherence (Kennedy, Goggin, & 
Nollen, 2004), glycemic control (Williams et al. 2004) and physical activity performance 
(Kinnafick, Thøgersen-Ntoumani, & Duda, 2014; Wilson et al., 2006).  
Autonomous rather than introjected and external motivation may be particularly salient in 
the completion of the HPV vaccine series. Parents who have internalized the benefits of 
vaccination and perceive themselves as having chosen to vaccinate their children because of 
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these benefits (i.e., parents who are autonomously motivated) would be more likely to overcome 
barriers to vaccination and receive the requisite follow-up doses. Successful completion of the 
series would not result from introjected or external reasons for vaccination as an individual 
vaccinating their child to avoid feelings of guilt, or to please their provider, has not personally 
endorsed the behavior and feels no genuine willingness to maintain activities for vaccine 
completion. Given these theoretical and empirical distinctions, the examination of the motivation 
underlying vaccination may allow us to understand the decisions to pursue further doses of HPV 
vaccination. 
Though SDT provides useful explanations for the reasons people engage in a behavior, it 
does not explain the processes by which motivation translates into behavior. Previous work has 
suggested that having greater self-determined motivation can lead to the development of positive 
attitudes and beliefs towards a behavior as well as higher perceived control, or competence 
(Williams et al., 1996; Williams et al., 2006). This process is suggested to occur through the 
internalization of beliefs whereby people are predisposed to form beliefs consistent with their 
motivation (Hagger & Chatzisarantis, 2009). Attitudes towards behavior and perceived control, 
or self-efficacy, both appear in the Theory of Planned Behavior (TPB, Ajzen, 1991). Thus, 
incorporating autonomous motivation into the TPB may explain the process by which motivation 
translates into behavior.  
Hagger & Chatzisarantis (2009; 2014) proposed an integration of autonomous motivation 
and TPB in the Integrated Behavior Change Model (IBC) that conceptualizes autonomous 
motivation as a precursor to the belief-based predictors in TPB with indirect effects on intentions 
and behavior.  Hypothesized connections between belief-based constructs in TPB (i.e., attitudes, 
self-efficacy, and norms) and self-determined motivation (i.e., that increased autonomous 
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motivation leads to more positive attitudes and higher self-efficacy and thus, increased intentions 
and behavior performance) support the integration of autonomous motivation into the TPB. 
However, this integrated model and the purported indirect effects of autonomous motivation on 
behavior via TPB variables have not been applied to HPV vaccination.  
Clarifying the pathways through which autonomous motivation influences behavior 
would facilitate the identification of psychological factors that are critical determinants of 
vaccination. The IBC model (Hagger & Chatzisarantis, 2014) suggests an indirect effect of 
autonomous motivation on both intentions to vaccinate and vaccine initiation through attitudes, 
self-efficacy, and subjective norms. However, SDT suggests autonomous motivation directly 
influences behavior. Additionally, there is evidence to suggest autonomous motivation may 
contribute to the prediction of health behaviors over and above vaccine intentions and the 
predictors included in the TPB (Ajzen, 1991; Hagger et al., 2002; McLachlan & Hagger, 2011). 
Thus, the role and importance of autonomous motivation differ between the IBC model and 
SDT. Previous work integrating autonomous motivation into the TPB has not compared the 
potential role of autonomous motivation as a proximal or distal factor influencing behavior.  
Brewer and Gilkey (2012) described two different methods of testing health behavior 
theories: a summary approach and a competitive hypothesis testing approach. To test theories 
using a summary approach, all predictors of two theories are measured, and the respective 
overall model fit and variance explained are compared to determine which theory best predicts 
the outcome. However, Brewer and Gilkey (2012) posit that use of a summary approach may be 
less appropriate when considering that theories are often “cross-pollinated” and rarely applied as 
initially proposed. Thus, they suggest an alternative, more flexible means of theory comparison: 
competitive hypothesis testing. In competitive hypothesis testing, areas where two theories have 
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differing explanations for associations between variables are identified and compared with the 
data. Though not common in health behavior research, competitive hypothesis testing could 
facilitate the identification of pathways critical to the application of theory to behavior (Brewer 
& Gilkey, 2012). The role of autonomous motivation in predicting behavior differs across 
theories. SDT argues that autonomous motivation directly influences behavior as a proximal 
influence, while the IBC theory conceptualizes autonomous motivation as a distal factor that 
affects behavior via its effect on attitudes, self-efficacy, norms, and intentions. Application of 
competitive hypothesis testing, rather than a summary approach, allows for testing of the 
alternative hypotheses by which autonomous motivation influences HPV vaccination. 
Current Study  
HPV vaccination rates remain suboptimal despite efforts to describe impediments and 
design interventions to promote early vaccination. To date, SDT and motivation have not been 
applied to the prediction of HPV vaccination. The present study aims to identify the effects of 
different types of motivation on vaccination behavior and to describe the mechanisms by which 
motivation may influence vaccination behavior among undecided parents. Autonomous 
motivation shows significant promise in explaining reasons for vaccination and providing a 
potential target for interventions to increase vaccine coverage.  
The objectives of this study are 1) to examine the relationships between different types of 
motivation and HPV vaccination initiation and completion, and 2) to test the pathways linking 
autonomous motivation, vaccine initiation, and attitudes, norms, self-efficacy, and vaccine 
intentions. I chose to focus on these variables because of previous work positing the integration 
of autonomous motivation and the TPB (Hagger & Chatzisarantis, 2009; 2014). To determine 
and quantify the effects of motivation on HPV vaccination initiation and completion, I conducted 
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a secondary analysis of data from a larger study to design and test the effects of a tablet-based 
intervention to promote HPV vaccination among undecided parents. I examined the influence of 
motivation on two primary outcomes: one-dose coverage (i.e., receipt of one or more doses of 
the vaccine), and three-dose coverage (i.e., receipt of three doses of the vaccine). I predicted that, 
consistent with SDT and previous work in other domains, autonomous motivation would be a 
stronger predictor of vaccination behavior than introjected and external motivation. In addition to 
these outcomes, to determine the effect that the changed dosing recommendations by the ACIP 
might have on the relationship between motivation and completion of the vaccine series, I 
examined the influence of motivation on a broader definition of completion that included the 
ACIP's new guidelines of receiving 2 doses over 6 months for individuals who began the vaccine 
series before age 15— “up-to-date” coverage. To test the alternative explanations of the role of 
autonomous motivation in influencing HPV vaccination proposed in SDT and the IBC model, I 
compared models comprising the direct and indirect effects of autonomous motivation via 
attitudes, norms, and self-efficacy on intentions to vaccinate and one-dose coverage. Explicitly, I 
tested the following research questions and associated hypotheses:   
RQ1.    To what extent do the three types of motivation (autonomous, introjected, and external) 
predict HPV vaccine series initiation (i.e., one-dose coverage)?   
a. I hypothesized that autonomous motivation would be a stronger predictor of HPV 
vaccine initiation than introjected and external motivation. 
 RQ2.    To what extent do the three types of motivation (autonomous, introjected, and external) 
predict HPV vaccine series completion (i.e., three-dose coverage or up-to-date coverage)? 
a. I hypothesized that autonomous motivation would be a stronger predictor of HPV 
vaccine completion than introjected and external motivation.  
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To test the competing pathways linking autonomous motivation to intentions to vaccinate and 
HPV vaccination, I tested competing models (i.e., direct versus indirect pathways) to address the 
questions: 
RQ3.    Does autonomous motivation a) directly influence intentions to vaccinate or b) indirectly 
influence intentions via attitudes, norms, and self-efficacy?  
RQ4.    Does autonomous motivation a) directly influence one-dose coverage or b) indirectly 
influence initiation via vaccine intentions? 
Method 
Data for the study was collected as part of the baseline survey of a multi-stage project to 
develop and test a tablet-based self-persuasion intervention to promote HPV vaccination among 
undecided parents (Baldwin et al., 2017; Shay et al., 2016; Tiro et al., 2016).  
Participants 
Demographics for parent participants and their adolescent are presented in Table 1. 
Participants (N = 177) consisted of undecided parents of unvaccinated adolescents ages 11-17 
identified through weekly electronic health record (EHR) reports identifying unvaccinated 
adolescents. Of the 177 participants, 36.7% (N=65) initiated the vaccine series, and 15.3% 
(N=27) received three doses by one-year follow-up. The number of individuals completing the 
series increased when considering those who met criteria for completion based on ACIP 
guidelines (N=3). The majority of the sample was female (97.2%), Spanish-speaking (58.8%), 
and Hispanic (68.9%). The majority of adolescents were also Hispanic (67.2%), and there was a 
nearly even split by adolescent sex (52.5% male). Parkland is a safety-net hospital serving low 
income, under- and uninsured populations in Dallas, TX. The IRB committees of both Southern 
Methodist University and the University of Texas Southwestern approved the study. Informed 
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consent was obtained from all participants, and participants were compensated with a $5 gift 
card for completion of the survey. 
Eligibility Criteria. Parents of eligible patients were mailed a letter inviting them to 
participate and provided with a toll-free number to ask questions or refuse participation. 
Invitation letters were sent in English or Spanish based on preferred language listed in the EHR. 
Bilingual research assistants then called parents of eligible patients, explained the project, and 
asked them to report their decision stage about the vaccine. Decision stage was assessed with a 
single item, “Which of the following best describes your thoughts about getting the HPV vaccine 
for your [daughter/son]?” Responses options included: (1) I have never thought about getting 
the HPV vaccine for him/her, (2) I am undecided about getting the HPV vaccine for [her/him], 
(3) I do not want to get the HPV vaccine for [her/him], and (4) I do want to get the HPV vaccine 
for [her/him]. Parents in the first two stages (i.e., never thought about the vaccine, undecided) 
were invited and consented. The research assistant then administered the baseline survey over the 
telephone. 
Measures 
Participants responded to the measures below on a 5-point Likert scale with answers 
ranging from (1) strongly agree to (5) strongly disagree. Scales were reversed such that higher 
values represented stronger agreement to simplify interpretation of analyses. Thus (1) 
represented strongly disagree and (5) represented strongly agree. Items were averaged within 
each scale to create mean scores. All items were adapted from previous research and displayed 
adequate reliability. Descriptive information for all items and constructs is displayed in Table 2. 
Motivation. Motivation was assessed with the Treatment Self-Regulation Questionnaire 
(TSRQ), a well-validated measure of motivation in health behavior (Levesque et al., 2007), 
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which has been successfully modified for application to HPV vaccination (Denman et al., 2016). 
The modified TSRQ consists of eight items assessing the different types of motivation. The stem 
for the eight items was “The reason you would get [child’s name] the vaccine is because…”. 
Items reflected three different types of motivation along the continuum. Four items represented 
autonomous motivation— e.g., “…because it is consistent with your goals as a parent.” Two 
items represented introjected motivation— e.g., “you would feel guilty or ashamed if you did 
not.” Two items represented external motivation— e.g., “you feel pressure from others to do 
so.” Responses within the three subscales were averaged to create mean scores for each scale.  
Self-Efficacy. Self-efficacy was assessed with two items reflecting participants' 
confidence in their ability to get their child the vaccine in the face of barriers [e.g., "You are 
confident that you can get the HPV vaccine for your child even if it means going to the clinic 
three times” (Gerend & Shepherd, 2012)].  
Intentions to Vaccinate. Intentions were assessed with three items asking about the 
likelihood of parents vaccinating their children [e.g. “In the next year, how likely is it that you 
will get the HPV vaccine for your child?” (Gerend & Shepherd, 2012)].  
Subjective Norms. Subjective norms were assessed with eight items that reflected the 
influence of friends and family in decision-making about the vaccine [e.g., "Your friends 
influence your decision about getting your child the HPV vaccine") (Allen et al., 2009; Gerend & 
Shepherd, 2012)]. 
Attitudes. Attitudes were assessed with six items that assessed parent’s beliefs regarding 
the positive nature of HPV vaccination for their adolescents [e.g. “Getting my child the HPV 
vaccine could save my child’s life” (Bynum et al., 2013; Gerend & Barley, 2009)]. 
AUTONOMOUS MOTIVATION AND HPV VACCINATION 
   
 
16 
Vaccination Behavior Outcomes. An electronic health record data pull on medical 
procedure codes matching administration of doses for the HPV vaccine yielded information on 
vaccination status, the number of received doses, and dates of vaccination one year after the date 
of randomization into the study. Vaccine initiation was operationalized as one-dose coverage 
(i.e., receipt of one or more doses of the vaccine within the 12-month study period). Thus, coding 
for one-dose coverage was inclusive of individuals who later received doses two and three of the 
vaccine.  Vaccine completion was operationalized as three-dose coverage (i.e., receipt of 3 doses 
of the vaccine within the study period). I also examined a broader definition of coverage—up-to-
date status- to determine the influence that changes in ACIP guidelines might have on the 
relationship between motivation and vaccination behavior. 
One-Dose Coverage. One-dose coverage was coded as a dichotomous variable—
individuals with 1 or more dose of the vaccine in their health record were given a 1 (N= 65), and 
those without a vaccine dose received a 0. Thus, one-dose coverage included individuals who 
also received doses two and three of the vaccine. 
Three-Dose Coverage. Three-dose coverage was coded as a dichotomous variable— 
individuals with three doses of the vaccine were given a 1 (N= 27), and those with < 3 doses 
were given a 0.  
Up-to-Date Coverage. Up-to-date coverage was conceptualized as a less-stringent 
definition of completion than three-dose coverage and counted individuals as having completed 
the vaccine series if they met the ACIP's new recommendations (Robinson et al., 2018). 
Adolescents were considered to be up-to-date if they had received three doses over the 12-month 
study period, or if they had received two doses and the first dose was received before age 15, and 
the lag between doses 1 and 2 was at least six months. Up-to-date coverage was coded as a 
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dichotomous variable—individuals who were up-to-date were given a 1 (N= 30), and those who 
had not met the new ACIP criteria or received three doses received a 0. Thus, coding for up-to-
date coverage included all individuals who counted in three-dose coverage as well as individuals 
who had completed based on the new guidelines (N= 3). 
Analytic Approach 
Analyses were conducted using IBM SPSS version 22 and MPlus version 8 software 
(Muthén & Muthén, 2012). Before data analysis, descriptive statistics were run on study 
variables (Table 1). Chi-square analyses were completed to determine group differences in 
predictors by parent's preferred language, adolescent age, and adolescent sex.  Additionally, I 
tested for differences between clinics. As data were drawn from a larger study to develop a tablet 
intervention to promote HPV vaccination, some participants (n = 35) were exposed to the 
intervention materials. Additionally, participants (n = 92) recruited for a different arm of the 
study were recruited based on an impending doctor's visit. These factors might have impacted 
vaccination rates. To account for these differences and other differences based on 
sociodemographic variables, all regression analyses controlled for recruitment arm, preferred 
language, adolescent age, and adolescent sex. There were no significant differences by clinic (p> 
.05), so this variable was not included as a covariate in analyses. 
Motivation Predicting HPV Vaccine Coverage. 
Logistic Regression Models. 
To determine whether autonomous, introjected and external motivation predicted the 
likelihood of one-dose coverage and three-dose coverage, I conducted multivariable (including 
autonomous, introjected, and external motivation as predictors) logistic regression models for 
each outcome. Because changes in ACIP guidelines might impact the relationship between 
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motivation and vaccine completion, I conducted an additional multivariable logistic regression 
models predicting the likelihood of up-to-date coverage.  
Ordinal Regression Models. 
To determine the influence of the different types of motivation on overall HPV vaccine 
coverage, I also conducted ordinal (proportional odds) regression analyses. Ordinal regression 
analyses predict the increased likelihood of an outcome that contains three or more ordered 
categories (e.g., receipt of dose two following receipt of dose one and receipt of dose three 
following receipt of the first two doses), based upon a one-unit change in the predictor. Ordinal 
regression is preferred to logistic regression models when the outcome has multiple categories as 
it preserves the information across categories that is lost when the outcome is "dichotomized" 
and when the distance between ordered categories is not equal. In the example of HPV 
vaccination, there are multiple transitions between doses (i.e., from 0 to 1 dose, 1 dose to 2 
doses, and 2 doses to 3 doses) and these transitions between doses vary in terms of time and 
effort (e.g., returning to the clinic for more doses outside of the annual visit schedule). Ordinal 
regression models assume the effect of the predictors is consistent across categories (the 
assumption of proportional odds) and thus provide an estimate of the overall effect of the 
predictors on the outcome. A multivariable ordinal regression was conducted to determine the 
effects of autonomous, introjected, and external motivation on vaccination behavior (i.e., receipt 
of zero, one, two, or three doses).  
Competitive Hypothesis Testing of Direct and Indirect Paths. 
  To determine whether the effect of autonomous motivation on intentions to vaccinate 
and vaccination behavior is direct or indirect, I used a competitive hypothesis testing strategy. I 
compared nested models comprising the competing hypotheses of direct and indirect effects of 
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autonomous motivation on intentions and vaccination based on chi-square difference tests. Using 
SDT and the IBC model as guides, I fit the following three models separately for each outcome 
as described in research questions 3 and 4: 1) a model with both direct and indirect pathways, 2) 
a model with only indirect pathways, 3) and a model with only direct pathways. Structural 
equation modeling was performed in MPlus version 8. For analyses predicting intentions to 
vaccinate, I used a maximum likelihood (ML) estimator. For analyses in which one-dose 
coverage was the outcome, I used a weighted least squares means and variance adjusted 
estimator (WLSMV) for modeling purposes to account for the dichotomous outcome and non-
normally distributed predictors (Kline, 2016). Latent factors were estimated for all constructs, 
and a measurement model was estimated. All factor loadings for latent variables were significant 
(ps < .001) and coefficient alpha was acceptable for all scales (Table 2). 
  The model with only direct pathways and the model with only indirect pathways were 
nested within the model with both direct and indirect pathways. These nested models allow for 
comparisons to determine whether both direct and indirect paths are necessary to maintain model 
fit. If model fit is reduced when comparing the model with both direct and indirect pathways to 
the model with only direct pathways, the indirect pathway is needed. If model fit is not reduced, 
according to the principle of parsimony, the indirect pathway can be removed (Raykov & 
Marcoulides, 1999). For research question 3 (Does autonomous motivation a) directly influence 
intentions to vaccinate or b) indirectly influence intentions via attitudes, norms, and self-
efficacy?), my first model with both direct and indirect effects (as shown in Figure 1) 
hypothesized a direct path from autonomous motivation to vaccine intentions and three indirect 
paths via attitudes, self-efficacy, and norms. My second model included only the direct path from 
autonomous motivation to vaccine intentions (c1), and my third model included only indirect 
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effects with the three pathways to intentions via self-efficacy, attitudes, and norms (a1 x b1, a2 x 
b2, a3 x b3). Parameter estimates are interpreted as regression coefficients. 
 For research question 4 (Does autonomous motivation a) directly influence one-dose 
coverage, or b) indirectly influence initiation via intentions?), my first model with direct and 
indirect effects (as shown in Figure 2) hypothesized a direct path from autonomous motivation to 
one-dose coverage and an indirect path via intentions (Fig 2). My second model included only 
the direct path from autonomous motivation to one-dose coverage (c1), and my third model 
included only the indirect effect with the pathway from autonomous motivation to one-dose 
coverage via intentions (a1 x b1).  
To determine which model best fit the data within each hypothesis, I compared models 
by calculating the c2 difference test statistic. A significant difference test statistic indicates the 
hypothesized model with the lower chi-square value fits the data better. A nonsignificant statistic 
suggests the more parsimonious model is best (Raykov & Marcoulides, 1999). The informal 
model fit was also assessed by computing the comparative fit index (CFI; values between .90 and 
.95 indicate adequate fit), root-mean-square error of approximation (RMSEA; values < .08 
indicate adequate fit and values < .06 indicate good fit), and chi-square values (Kline, 2016).  
Results 
Participant Characteristics 
 Demographics for parent participants and their adolescent are presented in Table 1. There 
were no significant differences in motivation (autonomous, introjected, or external) across 
recruitment arm or adolescent gender (ps > .05). However, Spanish-speakers demonstrated 
significantly higher levels of autonomous and introjected motivation (ps <.001).  No significant 
differences by language were evident in external motivation (p = .09). Additionally, chi-square 
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analyses indicated significant differences in one-dose coverage based on recruitment arm and 
parent-preferred language. Spanish speakers were more likely to initiate the vaccine series than 
English-speakers (p =.03). Moreover, there was a trend for adolescent gender to suggest that 
parents of adolescent females were more likely to initiate the vaccine than parents of adolescent 
males (p = .06). Independent samples t-tests were examined to determine differences in one-dose 
coverage by age. Younger adolescents were more likely to initiate the vaccine series (p < .001). 
To control for these differences, all regression models included adolescent age, gender, parent 
preferred language, and recruitment arm as covariates.  
Motivation Predicting HPV Vaccine Coverage 
Logistic Regression Models. 
  Autonomous motivation was associated with increased odds of one-dose coverage (i.e., 
receipt of one or more doses) in a multivariable, logistic regression model (OR = 2.47; 95%CI: 
[1.202, 5.079], p = .01). As predicted, neither introjected nor external motivation showed a 
significant effect in predicting one-dose coverage (Table 3). In a multivariable logistic regression 
model predicting three-dose coverage (i.e., receipt of three doses), greater autonomous 
motivation predicted three-dose coverage (OR = 2.68; 95%CI: [1. 00, 7.18], p = .05), but neither 
introjected, nor external motivation showed significant influence on three-dose coverage (ps > 
.05; Table 3). However, in a multivariable logistic regression model predicting up-to-date 
coverage, there were no significant effects of autonomous, introjected, or external motivation (ps 
> .05; Table 3). So, autonomous motivation predicted greater likelihood of vaccine initiation and 
completion (receipt of three doses), but there were no significant predictors of up-to-date 
coverage. 
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Ordinal Regression Models. 
 A cumulative odds ordinal logistic regression with proportional odds was conducted to 
determine the effects of the three different types of motivation on vaccination behavior (Table 4). 
The assumption of proportional odds was met, as assessed by a full likelihood ratio test 
comparing the fit of the proportional odds model to a model with varying location parameters, 
(p= .27). This indicates the influence of autonomous motivation was consistent across each 
transition between doses. An increase in autonomous motivation was significantly associated 
with greater odds of overall HPV vaccine coverage (OR = 2.452, 95% CI = 1.257, 4.786, p = 
.009).  However, consistent with logistic regression models, there were no significant 
associations between introjected and external motivation and HPV vaccine coverage (ps > .05). 
Consequently, results are indicative of a positive association between autonomous motivation 
and overall HPV vaccine coverage.  
Competitive Hypothesis Testing of Direct and Indirect Paths 
A measurement model with all latent constructs was estimated. All factor loadings were 
significant, and the measurement model displayed adequate fit (c2=223.10; CFI= .935; RMSEA= 
.058, 90% CI = .043, .072). Bivariate correlations between all latent constructs are displayed in 
Table 5.  
When I examined the effect of motivation on intentions, the model with both direct and 
indirect pathways (see Figure 3) fit the data better than both the model with only indirect 
pathways from autonomous motivation to intentions (c2 difference = 6.697, p = .01; 
Supplementary Figure 1) and the model with only direct pathways to intentions (c2 difference = 
86.194, p <.001; Supplementary Figure 2), suggesting both direct and indirect paths to 
intentions. Model comparisons are displayed in Table 6. Of note, the presence of both direct and 
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indirect pathways from autonomous motivation to intentions is contrary to the IBC, which 
proposed only indirect paths from autonomous motivation to intentions. Significant predictors of 
intentions included attitudes (standardized coefficient .32) and autonomous motivation (.39). 
Autonomous motivation showed significant associations with self-efficacy (.29), attitudes (.76), 
and subjective norms (.37). The indirect path from autonomous motivation to intentions via 
attitudes (.25) was also significant. Self-efficacy and subjective norms were not significantly 
associated with intentions to vaccinate (Figure 3). Thus, only an indirect effect of autonomous 
motivation through attitudes towards vaccination was evident.  
Examination of regression coefficients in the model with only indirect paths (See 
Supplementary Figure 1) and the model with only direct paths (Supplementary Figure 2) 
confirmed that across all three models, neither self-efficacy nor subjective norms showed 
significant associations with intentions. Within the model with only indirect paths, autonomous 
motivation showed significant associations with self-efficacy (.29), attitudes (.79), and subjective 
norms (.36) and the indirect path between autonomous motivation and intentions via attitudes 
was significant (.54, p<.001). Within the model with only direct paths (Supplementary Figure 2), 
both autonomous motivation and attitudes showed significant associations with intentions (.43, 
p< .001 and .41, p=.002, respectively).  
Attempts to estimate models describing the effect of autonomous motivation on 
vaccination behavior were adversely impacted by small sample size and, consequently, 
demonstrated poor fit. Compared to analyses using maximum likelihood estimators, models 
using weighted least squares means with variance adjustment (WLSMV) are less efficient and 
require larger sample size to achieve adequate power. Bandalos (2014) showed that with small 
samples sizes (less than 200) power for WLSMV estimation is often low and standard error bias 
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is high, but that as sample size increased error rates decreased and approached a nominal rate 
around a sample size of 500. Thus, these models were not deemed to be reliable and were not 
interpreted. Consequently, a determination of whether autonomous motivation has a direct, or 
indirect, effect on one-dose coverage could not be made at this time. 
Discussion 
Although motivation has been applied to numerous health behaviors, this research is 
some of the first to examine the effects of motivation in the context of HPV vaccination. 
Consistent with predictions based on Self-Determination Theory, these results suggest greater 
autonomous motivation, rather than introjected or external motivation, is associated with 
increased likelihood of both one- and three-dose coverage of the HPV vaccine. Thus, these 
findings strongly suggest that, for HPV vaccination, different types of motivation are important 
in parents’ decisions to vaccinate. Many past studies have demonstrated the importance of 
autonomous motivation in predicting health behavior performance (Howard et al., 2017; Ng et 
al., 2012). These findings support the application of autonomous motivation to HPV vaccination 
behavior. Moreover, these findings clarify the pathways linking autonomous motivation to 
intentions to vaccinate. 
Autonomous motivation was associated with HPV vaccine initiation; with increases in 
autonomous motivation, individuals had 2.5 times greater odds of receiving one or more doses of 
the vaccine. Moreover, greater autonomous motivation was associated with increased odds of 
three-dose coverage. I also conducted analyses investigating the impact of a different definition 
of completion (i.e., up-to-date coverage). I found the influence of autonomous motivation was 
less apparent when this less stringent definition of completion was applied. Given the modest 
effect of autonomous motivation on three-dose coverage, this decreased effect with a less 
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stringent definition of completion is likely related to an increase in “noise” in the relationship 
after recording those who received only two doses but met the ACIP guidelines as having 
"completed" the vaccine series (N=3). This may have resulted from lower levels of autonomous 
motivation among these parents relative to parents who received all three doses of the vaccine 
for their children. However, despite the lack of statistically significant influence of autonomous 
motivation on up-to-date coverage, across both models of completion (i.e., three-dose coverage 
and up-to-date coverage), increases in autonomous motivation were associated with nearly 
doubled odds of completing the vaccine series.  
Despite the mixed results for completion, examination of ordinal regression models 
provides a clearer picture of the overall effect of autonomous motivation across doses. The effect 
of autonomous motivation was consistent at each threshold between doses (e.g., receipt of dose 
two following receipt of dose one and receipt of dose three following receipt of the first two 
doses) and results indicated higher autonomous motivation was associated with 2.5 times greater 
likelihood of parents electing to pursue HPV vaccine completion. Thus, with each unit-increase 
in autonomous motivation, parents were more likely to get their child the vaccine (across all 
doses). Such analyses are not standard in the vaccination literature, where standard practice is to 
examine logistic regression models. However, application of an ordinal regression model 
provided an estimate of the overall influence of autonomous motivation on decisions to 
vaccinate. 
 Collectively, these findings strongly suggest that autonomous motivation is a vital factor 
in decisions to initiate and complete the vaccine series. A recent meta-analysis stressed the 
distinction between quality and quantity of motivation (Howard, Gagné, & Bureau, 2017). The 
authors highlighted the importance of having autonomous reasons for engaging in the behavior, 
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rather than having a higher amount of overall motivation (e.g., the amount of both controlled and 
autonomous motivation). These results support this distinction and suggest only autonomous 
motivation was predictive of vaccination behavior.  
Analyses also revealed differences in vaccination rates by sociodemographic 
characteristics. Results of descriptive analyses of the sample showed that younger adolescents 
were more likely to have initiated the vaccine series than older adolescents. Moreover, there was 
a trend to suggest females were more likely to meet criteria for one-dose coverage than males. 
Findings that younger adolescents and females are more likely to be vaccinated are consistent 
with previous studies (Bhatta & Phillips, 2015; Cowburn et al., 2014; Klosky et al., 2015; 
Rahman et al., 2015) and suggest that efforts to promote catch-up vaccination (vaccination after 
the target years of 11-12) among males and females, and vaccination more broadly among males, 
are necessary. Notably, vaccine recommendations typically focus on younger adolescents and 
preteens. Many parents indicate that they wish to wait to vaccinate until their child is older, but 
providers may fail to follow up with parents in later years, and older adolescents may have 
greater influence and input in the decision to obtain the vaccine than preteens. Furthermore, low 
vaccination rates among males may be related to the initial recommendations and marketing for 
the vaccine, which targeted females and highlighted benefits of the vaccine for female health 
(i.e., cervical cancer protection) and failed to discuss the benefits for males.  
The sample consisted of parents and adolescents treated at safety-net clinics. 
Consequently, the majority of the sample consisted of racial and ethnic minority parents with 
low education and low literacy. Additionally, more than half of the sample was Spanish-
speaking. Previous work examining HPV vaccination has found that vaccination rates are lowest 
among minority adolescents (Holman et al., 2014). Among this sample, Spanish-speaking 
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parents had higher autonomous motivation and were more likely to vaccinate their children than 
English-speaking parents. This finding is consistent with previous work showing Hispanic girls 
living in predominantly Hispanic communities had higher rates of HPV vaccine initiation 
compared to Hispanic girls living in majority Non-Hispanic White or Black communities (Henry 
et al., 2016). Additionally, past HPV vaccine studies have shown differences in vaccination rates 
between Spanish-speakers and English-speakers (Baldwin, Bruce, & Tiro, 2013; Stevens et al., 
2013). Previous work examining differential vaccination rates suggests that Hispanic individuals 
with lower levels of acculturation are more supportive of vaccination for children than 
individuals from other groups (Anderson et al. 1997, Henry et al., 2016). Some literature 
suggests these differences may be due to a lower sense of parental responsibility for vaccination 
among more highly acculturated parents (Prislin et al., 1998). For parents with a lower sense of 
parental responsibility, autonomy-supportive communication may address may be beneficial in 
eliciting more salient parental values and supporting more autonomously motivating perspectives 
(Williams et al., 2006). 
The present study also compared competing hypotheses for the paths by which 
autonomous motivation influences intentions to vaccinate and vaccination behavior. This 
competitive testing strategy was selected as it would allow for the comparison of areas where 
Self-Determination Theory and the Integrated Behavior Change model differ in their predictions 
regarding the role of autonomous motivation and its specific mechanisms of action on behavior. 
While Self-Determination Theory suggests a direct effect of autonomous motivation on behavior, 
the Integrated Behavior Change model purports only indirect effects of autonomous motivation 
on both intentions and behavior. Findings supported the presence of both direct and indirect 
pathways between autonomous motivation and intentions to vaccinate suggesting that one 
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mechanism by which autonomous motivation impacts behavior may be via intentions. Contrary 
to the IBC model, rather than indirect effects of autonomous motivation via attitudes, norms, and 
self-efficacy, only an indirect effect through attitudes was evident. Additionally, while 
autonomous motivation was related to both self-efficacy and subjective norms I found that self-
efficacy and norms were not associated with intentions to vaccinate. This finding contrasts with 
previous work suggesting positive associations between self-efficacy, norms, and intentions 
(Gerend & Shepherd, 2012). This may be due to measurement issues as both self-efficacy and 
subjective norms demonstrated the lowest reliability of all measures (a=.71 for both constructs). 
Alternatively, the lack of significant associations between self-efficacy, norms, and intentions 
may be related to the sample of undecided parents. Among parents who are ambivalent about the 
vaccine, there may be less reliable relationships between perceptions of ability to get the vaccine, 
the perceived importance of others’ opinions on vaccination, and intentions to vaccinate. Parents’ 
perceptions around the opinions of others and their own ability to get the vaccine may be less 
established or less meaningful in the context of ambivalence. In broader samples that include 
parents at all levels of vaccine decision-making, self-efficacy and norms might demonstrate 
significant associations with intentions to vaccinate, the indirect effects through self-efficacy and 
norms proposed in the IBC model could be evident. Collectively, results suggest that 
autonomous motivation is an essential predictor of intentions to vaccinate and consideration of 
autonomous motivation in the context of its effects on attitudes and intentions may be beneficial. 
While findings of both direct and indirect effects of autonomous motivation on intentions 
contrast with the predictions of the Integrated Behavior Change model, the implications suggest 
that intervening to increase autonomous motivation may be a feasible method of changing 
attitudes and increasing intentions to vaccinate. Future research should clarify the presence of 
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indirect effects through self-efficacy and norms using more reliable measures and tests 
interventions targeting autonomous motivation as a means of promoting vaccination by changing 
attitudes about vaccination. 
 The paths by which autonomous motivation influence vaccination behavior remain 
unclear.  Low power compromised model estimation examining the effects of autonomous 
motivation on vaccination behavior and these models were not interpreted at this time. While 
WLMSV is considered the best estimator for models with dichotomous outcomes, it is less 
efficient than maximum likelihood estimation, uses pairwise deletion, and typically requires 
larger sample sizes than models estimated with maximum likelihood (Bandalos, 2014). Thus, in 
addition to low power, missing data across predictors potentially impacted ability to estimate the 
model successfully. Given the paucity of studies examining the influence of autonomous 
motivation on vaccination behavior, future studies with larger sample sizes should test the direct 
paths between autonomous motivation and vaccination behavior to elucidate the mechanisms by 
which autonomous motivation influences vaccination. The potential presence of a direct effect of 
autonomous motivation on behavior highlights the importance of identifying interventions to 
increase autonomous motivation.  
Self-Determination Theory suggests that internalization of values is the mechanism of 
change for humans (Ryan & Deci, 1985; Williams et al., 2006). SDT-guided interventions have 
proven effective in increasing performance of other health behaviors that require repeated 
behavior performance (Williams et al., 2006). While such interventions have not been tested in 
the context of HPV vaccination, these findings support the utility of SDT-guided interventions to 
promote HPV vaccination.  
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Prior work to increase autonomous motivation for health outcomes has targeted 
autonomy support to facilitate autonomous motivation and competence (Ryan, Patrick, Deci, & 
Williams, 2008; Williams et al., 2006; Williams, Cox, et al., 1999; Williams & Deci, 2001; 
Williams et al., 1996; Williams et al., 1998). Autonomy support involves providing relevant 
information and soliciting choice, eliciting peoples' perspectives, and minimizing pressure 
(Williams et al., 2006). Thus, developing interventions targeting doctor’s recommendations may 
be a useful means of intervening to increase autonomous motivation.  
Doctor's recommendation is frequently cited as a critical predictor of vaccination (Bhatta 
& Phillips, 2015; Gilkey et al., 2016; Holman et al., 2014; Klosky et al., 2015). Currently, the 
CDC recommends “presumptive” provider recommendations for the HPV vaccine—assuming 
parents will decide in favor of vaccination—rather than participatory recommendations that 
allow for leeway (Opel et al. 2013; Shay et al. 2016). For some parents, however, a presumptive 
recommendation is not sufficient due to ambivalence or concerns about the vaccine. For these 
parents, an autonomy-supportive recommendation may be better suited to the promotion of 
decisions to vaccinate. Efforts to increase patient-centered care and autonomy-supportive 
recommendations may lead to increased autonomous motivation and vaccination behavior by 
acknowledging and addressing parents’ concerns and priorities for their children’s health. Use of 
an autonomy-supportive approach would also highlight the benefits of the vaccine, and thus 
foster autonomous motivation by helping parents understand the importance of the vaccine. 
Motivational interviewing (MI) also holds promise as a means of facilitating autonomous 
motivation among parents who remain ambivalent after receiving a recommendation. 
Motivational interviewing was initially developed in the addiction treatment field as a means of 
facilitating health behavior performance and is a style of communication that emphasizes 
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reflective listening, eliciting change talk, and shared decision-making (Rollnick, Miller, & 
Butler, 2008). The goal of motivational interviewing is often to work through ambivalence or 
resistance to behavior and MI has been applied to the promotion of several health behaviors 
(Dunn, Deroo, & Rivara, 2001). A recent intervention targeting provider communication 
supported the implementation of motivational interviewing with parents who were resistant to 
the vaccine and showed significantly higher HPV vaccine series initiation and completion 
(Dempsey et al., 2018). Future studies should build on these findings and develop interventions 
targeting parental motivation through autonomy-supportive communication styles and provision 
of information targeted to parents’ concerns.  
This study has several strengths. First, this data was longitudinal and allowed for the 
examination of the association between baseline motivation and subsequent vaccination 
behavior. Additionally, though the majority of studies on HPV vaccination behavior focus on 
initiation, with longitudinal data, I was able to examine completion of the vaccine series. 
Moreover, the use of structural equation modeling for competitive hypothesis testing facilitated a 
more stringent estimation of effects as well as the isolation of competing arguments (i.e., indirect 
vs. direct pathways from autonomous motivation to intentions to vaccinate; Brewer & Gilkey, 
2012). To date, competitive hypothesis testing has not been applied to the pathways linking 
autonomous motivation to intentions and behavior as proposed in the Integrated Behavior 
Change model (Hagger & Chatzisarantis, 2009; 2014). However, this method holds promise for 
enhancing understanding of the mechanisms of change for autonomous motivation and the 
advancement of theory. 
This study does have some limitations. First, the sample was restricted to parents who 
had never heard of the HPV vaccine or were undecided about vaccination. This limits 
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generalizability of these findings as parents who had decided for, or against, the vaccine were 
excluded. For parents who had already decided to vaccinate their adolescents, we might expect to 
see high levels of autonomous motivation. For parents who previously decided not to vaccinate 
their children, however, the underlying motivations are less predictable. For example, parents 
with negative perceptions about the HPV vaccine may report low levels of all types of 
motivation. Alternatively, parents with negative perceptions of the vaccine may be autonomously 
motivated against vaccination. Understanding the motivation underlying decisions not to 
vaccinate may be beneficial in promoting vaccination among parents who are ambivalent or 
resistant to vaccination. A related limitation of this study is the lack data on parental vaccine 
hesitancy and amotivation. According to Self-Determination Theory, amotivation is the lack of 
motivation to perform a behavior (Levesque et al., 2007). For some parents, amotivation and 
hesitancy may lead to decisions to delay the vaccine series until their child is older. Future 
studies should examine parents at all stages of decision-making and assess amotivation and 
vaccine hesitancy to understand how these constructs relate to refusal and delay of the vaccine. A 
further limitation of the study was the relatively small sample size, which was problematic in 
structural equation models examining one-dose coverage where sample size suggestions range 
from 200-500 when using a WLMSV estimator for dichotomous outcomes (Bandalos, 2014). 
Future research should examine direct and indirect pathways in larger samples that may allow for 
more accurate estimation of effects.  Moreover, the relatively short time frame for follow up (i.e., 
twelve months) was a limitation of this study. While the twelve-month time frame can be 
considered sufficient for completion based on the recommended vaccine schedule, few parents 
are sticking to this timeline. Practically, the majority of parents vaccinate their children during 
their annual, well-child visits (Dempsey et al., 2018; Dempsey, Abraham, Dalton, & Ruffin, 
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2009). Moreover, there is no evidence to suggest that completion on the recommended schedule 
is needed to maintain efficacy of the vaccine, so there is little incentive for parents or providers 
to adhere to the recommended dosing schedule. Examination of the overall rates of vaccination 
in Dallas County for 2016 reveals they are higher than rates in this study population (45.7% of 
adolescents had one-dose coverage, and 23.9% of adolescents had up-to-date coverage in 2016; 
Walker et al., 2017) and suggest that with more time, rates of adolescent vaccination would 
likely continue to rise. Thus, it is likely that with increased time for follow-up (e.g., two years) I 
would see an increased frequency of completion, and a stronger influence of autonomous 
motivation.  
Although I had temporal precedence of behavior, all predictors were measured at the 
same time and are correlational. This limits the ability to draw conclusions about the indirect 
versus direct effects of autonomous motivation on intentions. A future study assessing the 
indirect and direct effects of autonomous motivation on intentions measured at a later time or on 
behavior would provide a better estimation of these effects (Maxwell, Cole, & Mitchell, 2011).  
Finally, the sample consists of individuals receiving care in safety net clinics.  Low education, 
low health literacy, and low socioeconomic status overall characterize the sample as almost all 
patients seen at these clinics are under- or un-insured. It is possible that parents of higher 
education and SES might have other factors that impact vaccine decision-making and thus 
findings may not generalize to other populations. 
Conclusions 
  These findings suggest that autonomous motivation predicts a higher likelihood of HPV 
vaccine coverage. Additionally, findings from this study support the concept that the quality of 
motivation is critical in promoting behavior as neither introjected nor external motivation 
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showed any significant effect on vaccination behavior. Consequently, these findings support the 
utility of providing autonomy-supportive interventions. 
Results also suggest that considering autonomous motivation in the context of attitudes 
toward vaccination and intentions to vaccinate may be beneficial to facilitating understanding of 
the mechanisms by which it impacts behavior. Autonomous motivation was found to have both a 
significant indirect effect via attitudes and a direct effect on intentions to vaccinate. This 
suggests that autonomous motivation leads to the development of more positive attitudes and 
influences behavior through the internalization of beliefs as posited by the Self-Determination 
Theory. These findings provide a foundation upon which future research can expand through the 
development of autonomy supportive interventions to increase HPV vaccination.  
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Table 1. Participant Characteristics 
 Mean (SD) Range 
Autonomous Motivation 4.11 (.57) 2-5 
Introjected Motivation 2.93 (1.09) 1-5 
External Motivation 1.97 (.72) 1-4.5 
 N % 
Vaccination Rates   
   One-Dose Coverage 65 36.7 
   Three-Dose Coverage 27 15.3 
   Up-To-Date Coverage 30 16.9 
Parent Sex   
   Female 172 97.2 
   Male 5 2.8 
Parent Language   
   Spanish 104 58.8 
   English 73 41.2 
Parent Age   
   20-29 3 1.7 
   30-39 96 54.2 
   40-49 60 33.9 
   50 or older 18 10.2 
Parent Race/Ethnicity    
   Hispanic  122 68.9 
   Non-Hispanic Black  50 28.2 
   Non-Hispanic White  4 2.3 
   Unknown race/ethnicity  1 0.6 
Parent Education    
   Less than high school  37 20.9 
   Some high school  37 20.9 
   High school/Vocational degree  61 34.5 
   Some college/College graduate  42 23.7 
Adolescent Sex    
   Male  93 52.5 
   Female  84 47.5 
Adolescent Age   
   11-12 88 49.7 
   13-14 47 26.6 
   15-17 42 23.7 
Adolescent Race/Ethnicity    
   Hispanic  119 67.2 
   Non-Hispanic Black  48 27.1 
   Non-Hispanic White  4 2.3 
   Unknown race/ethnicity  6 3.4 
*Survey responses ranged from (1) strongly disagree to (5) strongly agree, thus higher values 
represent higher motivation. 
Running head: AUTONOMOUS MOTIVATION AND HPV VACCINATION  
 
Table 2. Factor Loadings Across All Latent Constructs 
Construct Loading p 
   
Autonomous Motivation (a=.82)   
The reason you would get [child’s name here] the vaccine is because you want to take responsibility for 
your child’s health. 
.546 <.001 
The reason you would get [child’s name here] the vaccine is because it is important. .823 <.001 
The reason you would get [child’s name here] the vaccine is because it is consistent with your goals as a 
parent. 
.723 <.001 
The reason you would get [child’s name here] the vaccine is because you believe it is the best thing for 
your child. 
.814 <.001 
Introjected Motivation (a=.75)   
The reason you would get [child’s name here] the vaccine is because you would feel guilty or ashamed if 
you did NOT. 
.75 <.001 
The reason you would get [child’s name here] the vaccine is because you would feel bad about yourself if 
you did NOT. 
.80 <.001 
External Motivation (a=.79)   
The reason you would get [child’s name here] the vaccine is because others would be upset with you if you 
did NOT. 
.82 <.001 
The reason you would get [child’s name here] the vaccine is because you feel pressure from others to do 
so. 
.81 <.001 
   
Intentions (a=.87)    
In the next year, how likely is it that you will think about getting the HPV vaccine for [child’s name here]? .744 <.001 
In the next year, how likely is it that you will get the HPV vaccine for [child’s name here]? .878 <.001 
In the next year, if a doctor or nurse at the clinic recommends the HPV vaccine for [child’s name here], 
how likely is it that you would get [child’s name here] the vaccine? 
.829 <.001 
   
Self-Efficacy (a=.71)   
You are confident that you can get the HPV vaccine for [child’s name here]. .735 <.001 
You are confident that you can get the HPV vaccine for [child’s name here], even if it means going to the 
clinic three times. 
.759 <.001 
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Attitudes (a=.81)   
Getting my child the HPV vaccine will be good for my child’s health. .803 <.001 
Other parents in my community are getting their children the HPV vaccine. .382 <.001 
Getting the HPV vaccine could save my child’s life. .705 <.001 
The HPV vaccine was well tested before being made available to the public. .664 <.001 
The benefits of having my child get the HPV vaccine are greater than the risks related to getting the 
vaccine. 
.577 <.001 
Getting the HPV vaccine will give me peace of mind about my child’s health. .779 <.001 
   
Norms (a=.71)   
Your spouse or partner influences your decision about getting [child’s name here] the HPV vaccine. .668 <.001 
Your family influences your decision about getting [child’s name here] the HPV vaccine. .660 <.001 
Your friends influence your decision about getting [child’s name here] the HPV vaccine. .402 <.001 
Your child’s doctor or nurse influences your decision about getting [child’s name here] the HPV vaccine. .524 <.001 
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Table 3. Logistic Regression Models 




      
       
Autonomous Motivation .866 .411 4.442 .035 2.378 1.063 - 5.320 
Introjected Motivation .197 .186 1.125 .289 1.218 .846 - 1.752 




      
       
Autonomous Motivation 1.310 .607 4.655 .031 3.706 1.127 - 12.182 
Introjected Motivation .124 .255 .237 .626 1.132 .687 - 1.868 
External Motivation .557 .368 2.295 .130 1.745 .849 - 3.587 
  
Motivation Predicting Up-
To-Date Coverage  
      
       
Autonomous Motivation .834 .544 2.349 .125 2.302 .793 - 6.687 
Introjected Motivation .136 .245 .308 .579 1.146 .708 - 1.853 
External Motivation .372 .360 1.066 .302 1.450 .716 – 2.93 
*All regression models controlled for recruitment arm, adolescent age, adolescent sex, and 
parent preferred language. 
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Table 4. Ordinal Regression Models 
Model B S.E. Wald p Exp(B) CI 95% 
Autonomous Motivation       
 .988 .403 6.014 .014 2.686 1.219 - 5.918 
Introjected Motivation       
 .168 .176 .908 .341 1.183 .837 - 1.671 
External Motivation       
 .223 .264 .715 .398 1.250  .745 - 2.098 
*All regression models controlled for recruitment arm, adolescent age, adolescent sex, and 
parent preferred language. 
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Table 5. Bivariate Correlations between Latent Variables 
Construct Attitudes Self-Efficacy Norms Intentions Autonomous 
Motivation 
Attitudes 1     
Self-Efficacy .262** 1    
Norms .110 .146 1   
Intentions .495** .138 .033 1  
Autonomous Motivation .612** .234** .082 .516** 1 
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Table 6. Fit indices for competitive model testing 
Model    c2 df CFI RMSEA CI 90% 
Direct & Indirect Paths 223.101 140 .935  .058 .043 - .072 
Direct Path Only 309.295 143 .869  .081 .069 - .093 
Indirect Paths Only 229. 798 141 .930  .060 .045 - .073 
    
Model Comparison    c2 difference df difference Significance testing 
    
Direct & Indirect Paths vs, 
Direct Path Only 
86.194 3 p= .000 
Direct & Indirect Paths vs. 
Indirect Paths Only 
6.697 1 p= .009 
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Figure 1. Proposed Model with Direct and Indirect Effects for Research Question 3 
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Figure 2. Proposed Model with Direct and Indirect Effects for Research Question 4 
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Figure 3. Final Model with Direct and Indirect Effects for Research Question 3 
 
 
Dashed lines represent nonsignificant paths. Solid lines represent significant paths.  
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Supplemental Figure 1. Final Model with only Indirect Effects 
 
 
Dashed lines represent nonsignificant paths. Solid lines represent significant paths.  
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Supplemental Figure 2. Final Model with only Direct Effects 
 
 
Dashed lines represent nonsignificant paths. Solid lines represent significant paths.  
*p < .05, ** p <.001 
 
 
 
 
 
 
